Kraj: Australia
Język: angielski
Źródło: Department of Health (Therapeutic Goods Administration)
Boston Scientific Pty Ltd
Class I
Baylis Medical Company Inc 5959 Trans-Canada Highway, Montreal, Quebec, H4T 1A1 Canada
47247 - Transseptal access system
The VersaCross Access Solution is indicated for creation of an atrial septal defect in the heart and for the percutaneous introduction of various types of cardiovascular catheters and guidewires to all heart chambers, including the left atrium via transseptal perforation/puncture.
A
2023-08-21